LONDON, July 07, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company's research report on the wearable ECG monitors market , healthcare service providers are increasingly using the data provided by medical devices to improve patient monitoring and overall care quality. The integration of medical device data with electronic medical records (EMR) to improve transparency and collaborations is gaining prominence among wearable ECG monitors industry trends. Hospitals that are becoming paperless and using the EMR to retrieve patient reports and data like ECGs now need an easy IT interface, interoperability, and digitally saved waveforms. As consumer wearables are becoming more common, patient data volumes are increasing, and companies are investing in deploying data management, warehousing, and security technologies. An example of wearable technology with analytics is the Wellue DuoEK Wearable EKG Monitor. It is a handheld and wearable device. The gadget can be placed on the fingers, thigh, or wrapped around the user's chest. For up to 15 minutes, the gadget captures the heartbeat and stores up to 10 sessions, or the user can download the Wellue app to keep an infinite number of sessions for free.
Request for a sample of the global wearable ECG monitors market report
The global wearable ECG monitors market size is expected to grow from $1.92 billion in 2021 to $2.7 billion in 2022 at a compound annual growth rate (CAGR) of 40.6%. The global wearable ECG devices market size is expected to grow to $6.27 billion in 2026 at a CAGR of 23.4%.
iRhythm Technologies, Inc. is a digital healthcare technology company that provides ambulatory electrocardiogram ("ECG") monitoring products. Its portfolio includes the Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians monitor patients and diagnose cardiac arrhythmias. The company employs around 1,700 people globally. iRhythm was founded in ...
Full story available on Benzinga.com